Cargando…
Development of Registry Data to Create Interactive Doctor-Patient Platforms for Personalized Patient Care, Taking the Example of the DESTINY System
“Real-world evidence (RWE)” is becoming increasingly important in order to integrate the results of randomized studies into everyday clinical practice. The data collection of RWE is usually derived from large-scale national and international registries, often driven by academic centers. We have deve...
Autores principales: | Bergmann, Arnfin, Stangel, Martin, Weih, Markus, van Hövell, Philip, Braune, Stefan, Köchling, Monika, Roßnagel, Fabian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521878/ https://www.ncbi.nlm.nih.gov/pubmed/34713104 http://dx.doi.org/10.3389/fdgth.2021.633427 |
Ejemplares similares
-
Implementation of a data control framework to ensure confidentiality,
integrity, and availability of high-quality real-world data (RWD) in the NeuroTransData
(NTD) registry
por: Wehrle, Knut, et al.
Publicado: (2022) -
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry
por: Braune, Stefan, et al.
Publicado: (2021) -
PHREND(®)—A Real-World Data-Driven Tool Supporting Clinical Decisions to Optimize Treatment in Relapsing-Remitting Multiple Sclerosis
por: Braune, Stefan, et al.
Publicado: (2022) -
Comparative effectiveness of delayed-release dimethyl fumarate versus interferon, glatiramer acetate, teriflunomide, or fingolimod: results from the German NeuroTransData registry
por: Braune, Stefan, et al.
Publicado: (2018) -
How do patients with secondary progressive multiple sclerosis enrolled in the EXPAND randomized controlled trial compare with those seen in German clinical practice in the NeuroTransData multiple sclerosis registry?
por: Braune, Stefan, et al.
Publicado: (2022)